Page last updated: 2024-12-06

uranium hexafluoride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

uranium hexafluoride: RN given refers to unlabeled cpd with MF of U-F6 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24560
CHEBI ID30235
MeSH IDM0111432

Synonyms (25)

Synonym
uranium hexafluoride
hexafluoridouranium
uranium(6+) fluoride
CHEBI:30235
[uf6]
7783-81-5
hexafluorouranium
uranium fluoride (uf6)
uranium fluoride
hsdb 4501
einecs 232-028-6
uranium hexafluoride, fissile excepted or non-fissile [un2978] [radioactive]
unii-n06gj1d94j
uranium fluoride (uf6), (oc-6-11)-
uranium hexafluoride, fissile excepted or non-fissile
uranium hexafluoride, fissile (with more than 1% u-2335) [un2977] [radioactive]
11133-71-4
uranium fluoride (u2f9)
12134-48-4
un 2978
uranium-238 hexafluoride
uranium fluoride (238uf6)
un 2977
uranhexafluorid
Q408887

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In 1998, storm water from the cylinder storage yards was found to be toxic to Ceriodaphnia, at concentrations exceeding limits in the site's discharge permit."( Source of toxicity in storm water: zinc from commonly used paint.
Konetsky, BK; Kszos, LA; Morris, GW, 2004
)
0.32

Dosage Studied

ExcerptRelevanceReference
" In general, the dog studies attest to the usefulness of the intravenous human studies for certain U6+ dose-response data and interface well with new retention data on intravenous uranyl citrate in dogs by Stevens et al."( Inhalation and intravenous studies of UF6/UO2F2 in dogs.
Beiter, H; Gelein, R; Morrow, P; Picano, J; Scott, J; Yuile, C, 1982
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
uranium halide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's1 (10.00)18.2507
2000's4 (40.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.58 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.87 (4.65)
Search Engine Demand Index83.62 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (55.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (9.09%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]